Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During Infection
Overview
Infectious Diseases
Microbiology
Authors
Affiliations
Vitamin D is a key regulator in calcium and phosphorus metabolism which are essential for maintaining bone health. Recent reports also showed a role for vitamin D in immune regulation which may be linked to vitamin D deficiency in autoimmune disorders including inflammatory diseases and Crohn's disease (CD). This study examines the role of vitamin D deficiency in the regulation of Cathelicidin Antimicrobial Peptide () in CD-like macrophages. The latter includes macrophages infected with subsp. (MAP) isolated from CD patient. Initially, we measured cathelicidin and calcitriol in plasma samples from CD patients with or without MAP infection ( per group). We also measured the expression and production of /LL-37, TNF-α, IL-1β, IL-10, cellular oxidative stress markers, and bacterial viability following treatment of MAP-infected macrophages with four different forms of vitamin D (D2, D3, calcifediol, and calcitriol). From these studies, we determined that LL-37 and calcitriol were significantly lower in CD samples from MAP-positive patients [155.55 ± 49.77 ng/mL and 51.48 ± 31.04 pg/mL, respectively] compared to MAP-negative patients [193.01 ± 78.95 ng/mL and 272.36 ± 94.77 pg/mL, respectively]. Moreover, calcitriol and calcifediol upregulated expression by nearly 5-fold and 3-fold, respectively. However, following MAP infection, only calcitriol increased by 3-folds. Both calcitriol and LL-37 reduced intracellular MAP viability by ~3 folds and inhibited TNF-α and IL-1β expression and production in these cells. Treating co-culture of Caco-2 monolayers and MAP-infected macrophages with LL-37 or calcitriol have shown a reduction in expression and DHE signal, in addition to a higher NADPH/NADPt ratio. Notably, calcitriol's anti-inflammatory effects were lost upon knockdown by CAMP-siRNA transfection. Altogether, the data indicate that MAP infection and burden is significant in CD by disrupting the conversion of calcifediol to calcitriol and downregulation of expression leading to vitamin D deficiency.
Recent advances in the therapeutic potential of cathelicidins.
Guerra M, Vieira B, Calazans A, Destro G, Melo K, Rodrigues E Front Microbiol. 2024; 15:1405760.
PMID: 38989014 PMC: 11233757. DOI: 10.3389/fmicb.2024.1405760.
Talafha M, Qasem A, Naser S Nutrients. 2024; 16(9).
PMID: 38732603 PMC: 11085596. DOI: 10.3390/nu16091358.
Enhancement of innate immunity in gingival epithelial cells by vitamin D and HDAC inhibitors.
Figgins E, Arora P, Gao D, Porcelli E, Ahmed R, Daep C Front Oral Health. 2024; 5:1378566.
PMID: 38567313 PMC: 10986367. DOI: 10.3389/froh.2024.1378566.
Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk.
Somoza-Moncada M, Turrubiates-Hernandez F, Munoz-Valle J, Gutierrez-Brito J, Diaz-Perez S, Aguayo-Arelis A Nutrients. 2023; 15(7).
PMID: 37049606 PMC: 10097210. DOI: 10.3390/nu15071765.
Zhang H, Yuan X, Yang Y, Wanyan Y, Tao L, Chen Y Cell Adh Migr. 2023; 17(1):20-34.
PMID: 36656313 PMC: 9858423. DOI: 10.1080/19336918.2023.2168231.